Medix (TSE:331A) EBIT: 円670 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:331A Medix Inc TSE:331A
19 GF Score
Price 円507.00
! 4 Warning Signs
View Full Analysis

What is Medix EBIT?

Medix TSE:331A +2.84% 19 EBIT is 円670 Mil as of Mar. 2026. GuruFocus rates TSE:331A with a GF Score™ of 19/100. The stock has 4 warning signs investors should review.

Medix's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2026 was 円428 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was 円670 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medix's annualized ROC % for the quarter that ended in Mar. 2026 was 37.56%. Medix's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 748.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medix's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 134.53%.

Medix  (TSE:331A) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medix's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=836.224 * ( 1 - 35.83% )/( (1267.102 + 1590.063)/ 2 )
=536.6049408/1428.5825
=37.56 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6828.972 - 1926.09 - ( 4182.778 - max(0, 2545.546 - 6181.326+4182.778))
=1267.102

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7732.233 - 2472.726 - ( 4064.327 - max(0, 3077.093 - 6746.537+4064.327))
=1590.063

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Medix's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=855.604/( ( (106.461 + max(-354.314, 0)) + (122.07 + max(-208.846, 0)) )/ 2 )
=855.604/( ( 106.461 + 122.07 )/ 2 )
=855.604/114.2655
=748.79 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1862.472 + 0 + 136.076) - (1926.09 + 0 + 426.772)
=-354.314

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2548.339 + 0 + 133.871) - (2472.726 + 0 + 418.33)
=-208.846

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medix's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=669.983/498.028
=134.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medix EBIT Related Terms

Medix EBIT Historical Data

* Premium members only.

The historical data trend for Medix's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medix EBIT Chart

Medix Annual Data
Trend Mar23 Mar24 Mar25 Mar26
EBIT
641.40 791.44 954.27 669.98

Medix Semi-Annual Data
Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EBIT Get a 7-Day Free Trial 0.00 402.16 552.11 242.18 427.80

TSE:331A vs APP, OMC, TTD: EBIT Comparison

For the Advertising Agencies subindustry, Medix's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medix EV-to-EBIT vs Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, Medix's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medix's EV-to-EBIT falls into.


TSE:331A
19GF Score
Medix Inc TSE:331A
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medix EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円670 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円670 Mil mean?
Medix (TSE:331A) has a EBIT of 円670 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medix.
Is Medix's EBIT too high?
Medix's current EBIT is 円670 Mil. Overall, Medix has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medix's EBIT compare to APP and OMC?
Medix's EBIT of 円670 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Media - Diversified company?
A good EBIT depends on the Media - Diversified industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Medix. Medix's current EBIT is 円670 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medix stock overvalued right now?
Medix (TSE:331A) has a current EBIT of 円670 Mil. The current EBIT is 円670 Mil. Medix's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Medix (TSE:331A), the current EBIT is 円670 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medix Business Description

Address 1-105 Kanda-Jinbo-cho, 19th Floor, Jimbocho Mitsui Building, Chiyoda-ku, Tokyo, JPN, 101-0051
Medix Inc is an internet advertising agency that places the utmost importance on understanding its clients' business models deeply and helping them solve problems over the medium to long term. It is engaged in Digital marketing services including creative design and production, data parsing and analysis, and Internet advertising services. The company provides services in the digital marketing field to clients in various lines and industries.
19GF Score

Get the complete analysis for TSE:331A

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円507.00
Price